Sexually Transmitted Diseases Testing Market Size & Share

1. Global STD Testing Market Analysis The global sexually transmitted diseases (STD) testing market is projected to reach $19.91 billion by 2032, growing from $10.26 billion in 2024 at an 8.7% CAGR. Market Leadership & Regional Analysis North America dominates with a 42.69% market share in 2024, driven by public-private partnerships and increased disease awareness1. The U.S. STD testing market alone is expected to reach $6.87 billion by 2030. Key Market Segments By Product Type  Reagents & Kits (market leader)  Instruments By Application  Chlamydia (largest segment)  Syphilis  Genital herpes  Gonorrhea  HIV  HPV  Others By Testing Setting  Laboratory testing (dominant)  Point-of-care testing (fastest growing) Market Drivers 1.Rising Disease Incidence  38.4 million people living with HIV in 2021  491 million people aged 15-49 have HSV-2 infection globally 2.Government Initiatives  Brazil's partnership with Johns Hopkins University for low-cost syphilis testing  India's "Suraksha Clinics" offering free STI testing services COVID-19 Impact The pandemic caused a 30% drop in positive test results through Electronic Laboratory Reporting in the U.S. from April 2019 to April 20201. However, testing levels recovered by 2021, with Abbott reporting a 3.9% recovery in their diagnostic business segment.

2. Market Trends The industry is shifting from laboratory to point-of-care testing, driven by:  Faster turnaround time  Lower costs  Reduced social stigma  Improved accessibility Key Industry Players Leading companies include:  Abbott  bioMerieux Inc.  Bio Rad Laboratories Inc.  DiaSorin S.p.A  Cepheid (Danaher)  Hologic, Inc.  F. Hoffmann-La Roche Ltd. Footnotes Fortune Business Insights - Sexually Transmitted Diseases Testing Market Size https://www.fortunebusinessinsights.com/industry-reports/sexually-transmitted-diseases-testing- market-101095